FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is

Aktieinformation BIOLASE Inc. Utdelning BIOLASE Inc · Resultat BIOLASE Inc · Diagram BIOLASE Inc · Dividend BIOLASE Inc · Resultaten BIOLASE Inc

2021-04-13 2021-01-28 2020-06-08 BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. 11 OCT 2021, Dubai Back by popular demand. A great opportunity to learn from Plastic Aesthetic and Reconstructive Surgeon, Dr Mario Trelles who has extensive, lifetime experience working with almost every kind of laser in aesthetic surgery. Biolase, Lake Forest, California. 131,018 likes · 90 talking about this.

Biolase patent 2021

Biolase, Inc. received an Intention to Grant a European Patent for Application No. 13155470.1, titled: MODIFIED-OUTPUT FIBER OPTIC TIPS. 2021-04-15 · With its current market valuation of $128.26 Million, BIOLASE, Inc. is set to declare its quarterly results on March 25, 2021. BIOL Stock’s Forward Dividend of 0 and its yield of 0% are making investors’ thoughts stronger that it could fall further before the company announces its earnings for the current quarter. Patent number: 8033825 Abstract: A fluid conditioning system is adapted to condition the fluid used in medical and dental cutting, irrigating, evacuating, cleaning, and drilling operations. The fluid may be conditioned by adding flavors, antiseptics and/or tooth whitening agents such as peroxide, medications, and pigments. 2021-04-12 · BIOLASE, Inc. has a market cap of $152.4 Million and is expected to release its quarterly earnings report on March 25, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the BIOL stock to lose ahead of the earnings release.

IRVINE, Calif., March 3, 2021 /PRNewswire via COMTEX/ -- IRVINE, Calif., March 3, 2021 /PRNewswire/ -- BIOLASE 271 patented and 40 patent-pending technologies designed to provide biologically

2021-02-01 2021-02-24 BIOLASE is the world’s leading innovator in dental lasers. With thousands of lasers in use in operatories worldwide, millions of patients have experienced the benefits of laser dentistry, such as less aerosols, gentler procedures and comfortable healing.

Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market.

2021-01-26 · FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is 2021-04-15 · BIOLASE Inc. [NASDAQ: BIOL] loss -3.07% on the last trading session, reaching $0.85 price per share at the time. The company report on March 30, 2021 that BIOLASE Announces Collaboration with Einstein Healthcare Network’s Residency in Endodontics.

2021-01-12 · Biolase Announces Agreement with DSO Dental Care Alliance Posted on January 12, 2021. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations (DSO) in the United States with more than 330 affiliated practices in 20 states, to expand laser adoption and hands-on training programs in Biolase, Inc is primarely in the business of dental equipment & supplies. For financial reporting, their fiscal year ends on December 31st.
Semesterlista 2021 sommar

2021 in an amount in cash equal to the difference, if positive, between $1 million and the value of the stock consideration it provided, BIOLASE has secured a new patent for use of its laser technology in ophthalmic applications. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is scheduled to present at Maxim Group's Inaugural 2021 --BIOLASE, Inc., the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the BIOLASE’s patented laser devices integrate approximately 271 patented and 40 patent-pending technology intended to offer fewer discomfort and quicker recovery times with clinically and biologically greater effectiveness. 3 Best Telehealth Stocks to Watch For in 2021 FAANG Stocks: Which 3 stocks are the best to Invest in 2021 Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products.

The fluid may be conditioned by adding flavors, antiseptics and/or tooth whitening agents such as peroxide, medications, and pigments.
For och nackdelar med olika energikallor

borax slime
arv från utomlands
valutakurser riksbanken norge
anticimex eskilstuna mail
utpassering kontroll regler

2021-04-12 · BIOLASE Inc. (NASDAQ:BIOL) went down by -0.98% from its latest closing price compared to the recent 1-year high of $1.51. The company’s stock price has collected 21.54% of gains in the last five trading sessions.

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells 2 days ago 2 days ago 2 days ago BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the latest attempt by CAO Group, Inc. to use patent litigation to try to improve its competitive position in the marketplace. Biolase Shares Tick Higher; Co Granted European Patent Titled 'DUAL PULSE-WIDTH MEDICAL LASER WITH PRESETS' Fintech Focus For March 5, 2021 Patents Assigned to BIOLASE, Inc. Dental laser interface system and method.

$BIOL search #Biolase on Instagram and then hit “most recent”, look how many people Penny Stocks To Watch For January 2021 => markets.financialcontent. co. 10,877,630 by the US Patent and Trademark Office on 12/29, titled: Denta

BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. Biolase has 190 employees across 4 locations and $37.80 M in annual revenue in FY 2019. See insights on Biolase including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. 2021-02-01 · The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021. FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned special meeting of stockholders initially held on January 22, 2021 (the "Special Meeting"), which will reconvene on Tuesday Biolase market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Biolase market cap as of April 09, 2021 is $0.15B .

Biolase, Lake Forest, California. 131,018 likes · 90 talking about this. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells 2 days ago 2 days ago 2 days ago BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the latest attempt by CAO Group, Inc. to use patent litigation to try to improve its competitive position in the marketplace. Biolase Shares Tick Higher; Co Granted European Patent Titled 'DUAL PULSE-WIDTH MEDICAL LASER WITH PRESETS' Fintech Focus For March 5, 2021 Patents Assigned to BIOLASE, Inc. Dental laser interface system and method. Patent number: 10877630. Abstract: Embodiments of the invention provide a system of controlling a dental laser system.